Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses —————— — Research & development —————— — Operating income -143.29 K-209.47 K-169.99 K-292.54 K-168.82 K-220.15 K -851.5 K Non-Operating Income, Total 597.16 K608.45 K622.31 K561.34 K380.78 K304.81 K 1.87 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 597.16 K608.45 K622.31 K561.34 K380.78 K304.81 K 1.87 M Unusual income/expense —————— — Pretax income 453.87 K398.98 K452.32 K268.8 K211.96 K84.66 K 1.02 M Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 453.87 K398.98 K452.32 K268.8 K211.96 K84.66 K 1.02 M Discontinued operations —————— — Net income 453.87 K398.98 K452.32 K268.8 K211.96 K84.66 K 1.02 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 453.87 K398.98 K452.32 K268.8 K211.96 K84.66 K 1.02 M Basic earnings per share (Basic EPS) 0.120.10.140.040.060.1 — Diluted earnings per share (Diluted EPS) 0.120.10.140.040.060.1 — Average basic shares outstanding 15 M15 M15 M14.92 M11.9 M11.05 M — Diluted shares outstanding 7.5 M7.5 M7.5 M7.46 M5.95 M5.52 M — EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —